Brought to you by:
Abbott announces agreement to acquire Cardiovascular Systems
Abbott and Cardiovascular Systems (CSI) have announced a definitive agreement for Abbott to acquire CSI. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million, according to…
Envision, private equity and patient care: Substituted values 2.0
He was only 41, already burdened with multiple health problems. Diabetes, hypertension and renal failure had put him on dialysis, caused the amputation of his left leg, and now left him with poor circulation in his right leg. Signs of…
Summit dedicated to tackling key issues related to women’s vascular health and female workforce seeks to ‘enable and empower’
Linda Harris, MD, is a prolific attendee on the national and regional vascular meeting circuit, a noteworthy academic vascular surgeon with trainees and papers on the scientific session plate, and a curious questioner of new research offered up from the…
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled trial (RCT) raised some of the early fault lines developing between different interpretations of the study’s key…
Students and residents: Attend VAM 2023 on a scholarship
Medical students and general surgery residents have the chance to change their lives. Perhaps they are still seeking some direction for their medical careers. Perhaps they’re considering vascular surgery but aren’t sure that’s right for them. A trip to the Society…
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis, VQI registry data show
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry-based, postmarket surveillance study. This is according to Daniel Bertges, MD, a vascular surgeon…